luzindole has been researched along with cytochrome c-t in 1 studies
| Studies (luzindole) | Trials (luzindole) | Recent Studies (post-2010) (luzindole) | Studies (cytochrome c-t) | Trials (cytochrome c-t) | Recent Studies (post-2010) (cytochrome c-t) |
|---|---|---|---|---|---|
| 265 | 1 | 119 | 11,809 | 21 | 5,125 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cerella, C; Cristofanon, S; D'Alessio, M; De Nicola, M; Dicato, M; Diederich, M; Ghibelli, L; Paternoster, L; Radogna, F | 1 |
1 other study(ies) available for luzindole and cytochrome c-t
| Article | Year |
|---|---|
Melatonin antagonizes the intrinsic pathway of apoptosis via mitochondrial targeting of Bcl-2.
Topics: Apoptosis; bcl-2-Associated X Protein; Cytochromes c; Humans; Melatonin; Microscopy, Fluorescence; Mitochondria; Proto-Oncogene Proteins c-bcl-2; Puromycin; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; RNA, Small Interfering; Tryptamines; U937 Cells | 2008 |